Back to search

Article

Virological and Clinical Outcomes in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia

2023-07-10

Abstract excerpt

The emergence of new SARSCoV-2 variants can affect vaccine efficacy, laboratory diagnosis and therapies already available, triggering interest in the search for antiviral agents for SARSCoV-2 infections. Ribavirin (RBV) is a broad-spectrum antiviral with demonstrated in vitro activity against multiple viruses, including SARSCoV-2. Methods. This retrospective study evaluated the dynamic and viral clearance of SARSC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1b65aab2-b1b7-5228-9e8f-c5c50e87744a
DOI
10.20944/preprints202307.0601.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Virological and Clinical Outcomes in Adults Treated with Ribavirin Aerosol for COVID-19 PneumoniaDOI 10.20944/preprints202307.0601.v1
Select a neighboring publication to make it the new centre.